Tower Research Capital »

Cadrenal Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Cadrenal Therapeutics (CVKD) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Cadrenal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cadrenal Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cadrenal Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.8k 9.5k 0.61
2023-09-30 $5.8k 8.5k 0.68
2023-06-30 $407 270 1.51
2023-03-31 $999 607 1.65